BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21518409)

  • 1. Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene.
    Bennett K; James C; Mutair A; Al-Shaikh H; Sinani A; Hussain K
    Pediatr Diabetes; 2011 May; 12(3 Pt 1):192-6. PubMed ID: 21518409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
    Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
    Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nonsense mutation in GCK exon 9 co-segregates with diabetes phenotype.
    Knebel B; Jacob S; Boxberg CV; Müller-Wieland D; Kotzka J
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):298-301. PubMed ID: 15216446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permanent neonatal diabetes caused by a homozygous nonsense mutation in the glucokinase gene.
    Rubio-Cabezas O; Díaz González F; Aragonés A; Argente J; Campos-Barros A
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):245-9. PubMed ID: 18298419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families.
    Velho G; Blanché H; Vaxillaire M; Bellanné-Chantelot C; Pardini VC; Timsit J; Passa P; Deschamps I; Robert JJ; Weber IT; Marotta D; Pilkis SJ; Lipkind GM; Bell GI; Froguel P
    Diabetologia; 1997 Feb; 40(2):217-24. PubMed ID: 9049484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young.
    Mantovani V; Salardi S; Cerreta V; Bastia D; Cenci M; Ragni L; Zucchini S; Parente R; Cicognani A
    Hum Mutat; 2003 Oct; 22(4):338. PubMed ID: 12955723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
    Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA
    Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable presentations of
    Oza CM; Karguppikar MB; Khadilkar V; Khadilkar A
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35228227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
    Turkkahraman D; Bircan I; Tribble ND; Akçurin S; Ellard S; Gloyn AL
    J Pediatr; 2008 Jul; 153(1):122-6. PubMed ID: 18571549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent.
    Gozlan Y; Tenenbaum A; Shalitin S; Lebenthal Y; Oron T; Cohen O; Phillip M; Gat-Yablonski G
    Pediatr Diabetes; 2012 Sep; 13(6):e14-21. PubMed ID: 21978167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucokinase gene mutation screening in Argentinean clinically characterized MODY patients.
    Lopez AP; Foscaldi SA; Pérez MS; Krochik G; Rodríguez M; Traversa M; Puchulu FM; Hirschler V; Bergada I; Frechtel GD
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):391-4. PubMed ID: 19358091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucokinase gene abnormalities in maturity-onset diabetes of the young (MODY) and late-onset NIDDM].
    Odawara M
    Nihon Rinsho; 1994 Oct; 52(10):2580-6. PubMed ID: 7983782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
    Massa O; Iafusco D; D'Amato E; Gloyn AL; Hattersley AT; Pasquino B; Tonini G; Dammacco F; Zanette G; Meschi F; Porzio O; Bottazzo G; Crinó A; Lorini R; Cerutti F; Vanelli M; Barbetti F;
    Hum Mutat; 2005 Jan; 25(1):22-7. PubMed ID: 15580558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
    López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
    Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in the age at diagnosis of diabetes in two unrelated patients with a homozygous glucokinase gene mutation.
    Durmaz E; Flanagan S; Berdeli A; Semiz S; Akcurin S; Ellard S; Bircan I
    J Pediatr Endocrinol Metab; 2012; 25(7-8):805-8. PubMed ID: 23155716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online.
    Guazzini B; Gaffi D; Mainieri D; Multari G; Cordera R; Bertolini S; Pozza G; Meschi F; Barbetti F
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY).
    Cao H; Shorey S; Robinson J; Metzger DL; Stewart L; Cummings E; Hegele RA
    Hum Mutat; 2002 Dec; 20(6):478-9. PubMed ID: 12442280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ancestral mutations may cause a significant proportion of GCK-MODY.
    Dusatkova P; Pruhova S; Borowiec M; Vesela K; Antosik K; Lebl J; Mlynarski W; Cinek O
    Pediatr Diabetes; 2012 Sep; 13(6):489-98. PubMed ID: 22332836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.